Key result
Anticoagulation resolves recurrent bioprosthetic mitral valve thrombosis in a case report, preventing re-operation.
Why the study?
Bioprosthetic valve thrombosis is more common than previously thought, likely underreported, and can be accurately diagnosed and treated with anticoagulation to prevent re-operation.
Anticoagulation is a viable treatment for recurrent bioprosthetic mitral valve thrombosis to prevent re-operation.
Answers are grounded in this paper and cite their sources.
May support anticoagulation to avoid reoperation in recurrent bioprosthetic mitral valve thrombosis; hypothesis-generating and requires prospective confirmation.
Bioprosthetic valve thrombosis (BPVT) is more common than previously thought and likely underreported. BPVT can be accurately diagnosed with cardiac imaging and treated successfully with anticoagulation, thus preventing re-operation. We hereby report a case of recurrent BPVT in the mitral position successfully treated with anticoagulation along with review of literature.
No takes yet. Share an insight, caveat, or question.
Fernandes et al. (2020) studied this question. Anticoagulation successfully treated recurrent bioprosthetic mitral valve thrombosis in a reported case, preventing the need for re-operation.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: